IDEAS home Printed from https://ideas.repec.org/a/taf/regstd/v36y2002i3p275-289.html
   My bibliography  Save this article

Project Teams as Means of Restructuring Research and Development in the Pharmaceutical Industry

Author

Listed:
  • Christian Zeller

Abstract

This paper investigates the strategic and organizational changes which two major Swiss pharmaceutical companies have implemented in order to respond to the challenges related to a slowing of innovation and increasing oligopolistic rivalry. Introducing cross-functional project teams, the companies mainly accelerated the development process. These project teams are overlaying structures which complement the functional and geographical organizational units. Common project teams and steering committees are instruments to manage collaborations between pharmaceutical and biotech companies. This paper argues that project teams change power relations, reflect rationalization efforts and serve to create organizational and cultural proximity which is important to guarantee knowledge flows within and between firms. Cet article examine les changements strategiques et organisationnels mis en oeuvre par deux grandes societes pharmaceutiques suisses afin de relever les defis lies au ralentissement de l'innovation et ala hausse de la concurrence oligopolistique. En mettant en place des equipes de projet multi-fonctionnelles, les societes ont pour la plupart accelere le processus de developpement. Ces equipes de projet constituent des structures qui recouvrent et completent les unites d'organisation fonctionnelles et geographiques. Des equipes de projet et des comites directeurs communs sont des instruments pour administrer la collaboration entre les societes pharmaceutiques et biotechnologiques. Cet article affirme que les equipes de projet influent sur la repartition des pouvoirs, refletent les efforts de rationalisation et servent a creer la proximiteorganisationnelle et culturelle qui est importante afin d'assurer le flux de connaissances intra et interentreprises. Der Artikel untersucht die strategischen und organisatorischen Veranderungen, die zwei wichtige schweizerische Pharmakonzerne implementiert haben, um auf die Herausforderungen des Innovationsdefizits und der verscharften oligopolistischen Rivalitat zu antworten. Mit der Einfuhrung von functions ubergreifenden Projektteams haben die Unternehmen hauptschlich den Entwicklungsprozess beschleunigt. Diese Projektteams sind erganzende Strukturen, die die funktionalen und geographischen Organisationseinheiten-berlagern. Projektteams und gemeinsame Steuerungsgremien sind Instrumente, um die Kooperationen zwischen Pharma- und Biotechunternehmen zu leiten. Der Artikel argumentiert, dass Projektteams die Machtverhaltnisse verandern, organisatorischer Ausdruck von Rationalisierungsmanahmen sind und dazu dienen, organisatorische und kulturelle Nahe zu schaffen. Diese ist wichtig, um die Wissensflusse innerhalb von und zwischen Firmen zu garantieren.

Suggested Citation

  • Christian Zeller, 2002. "Project Teams as Means of Restructuring Research and Development in the Pharmaceutical Industry," Regional Studies, Taylor & Francis Journals, vol. 36(3), pages 275-289.
    • Handle: RePEc:taf:regstd:v:36:y:2002:i:3:p:275-289
    DOI: 10.1080/00343400220122070
    as

    Download full text from publisher

    File URL: http://www.tandfonline.com/doi/abs/10.1080/00343400220122070
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1080/00343400220122070?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Mowery,David C. & Nelson,Richard R. (ed.), 1999. "Sources of Industrial Leadership," Cambridge Books, Cambridge University Press, number 9780521645201, October.
    2. Blanc, Helene & Sierra, Christophe, 1999. "The Internationalisation of R&D by Multinationals: A Trade-off between External and Internal Proximity," Cambridge Journal of Economics, Cambridge Political Economy Society, vol. 23(2), pages 187-206, March.
    3. Gerybadze, Alexander & Reger, Guido, 1999. "Globalization of R&D: recent changes in the management of innovation in transnational corporations," Research Policy, Elsevier, vol. 28(2-3), pages 251-274, March.
    4. Lundin, Rolf A. & Söderholm, Anders, 1995. "A theory of the temporary organization," Scandinavian Journal of Management, Elsevier, vol. 11(4), pages 437-455, December.
    5. Christophe Sierra, 1997. "Proximité(s), interactions technologiques et territoriales : une revue," Revue d'Économie Industrielle, Programme National Persée, vol. 82(1), pages 7-38.
    6. Florida, Richard, 1997. "The globalization of R&D: Results of a survey of foreign-affiliated R&D laboratories in the USA," Research Policy, Elsevier, vol. 26(1), pages 85-103, March.
    7. Nightingale, Paul, 2000. "Economies of Scale in Experimentation: Knowledge and Technology in Pharmaceutical R&D," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 9(2), pages 315-359, June.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Stephen Roper & James Love & Priit Vahter, 2012. "The value of design strategies for new product development: Some econometric evidence," The Centre for Small and Medium Sized Enterprises Research Paper Series 114, Centre for Small and Medium Sized Enterprises, Warwick Business School, University of Warwick.
    2. Mangematin, V. & Blanco, S. & Deschamp, B. & Genet, C. & Kahane, B., 2006. "Project management : learning by breaking the rules," Working Papers 200604, Grenoble Applied Economics Laboratory (GAEL).
    3. Ana Paula Faria & Natália Barbosa & Vasco Eiriz, 2013. "Firms’ innovation across regions: an exploratory study," NIPE Working Papers 12/2013, NIPE - Universidade do Minho.
    4. Friedrich Dornbusch & Sidonia von Proff & Thomas Brenner, 2013. "The organizational and regional determinants of inter-regional collaborations – Academic inventors as bridging agents," Working Papers on Innovation and Space 2013-11, Philipps University Marburg, Department of Geography.
    5. Vincent Mangematin & Khalid Errabi, 2012. "The Determinants Of The Science-Based Cluster Growth: The Case Of Nanotechnologies," Grenoble Ecole de Management (Post-Print) hal-00526701, HAL.
    6. Friedrich Dornbusch & Thomas Brenner, 2013. "Universities as local knowledge hubs under different technology regimes – New evidence from academic patenting," Working Papers on Innovation and Space 2013-10, Philipps University Marburg, Department of Geography.
    7. Ina Drejer & Anker Lund Vinding, 2006. "Organisation, 'anchoring' of knowledge, and innovative activity in construction," Construction Management and Economics, Taylor & Francis Journals, vol. 24(9), pages 921-931.
    8. James Love & Stephen Roper, 2009. "Organizing the Innovation Process: Complementarities in Innovation Networking," Industry and Innovation, Taylor & Francis Journals, vol. 16(3), pages 273-290.
    9. Heydebrand, Wolf, 2009. "Accounting for great expectations: Lessons from the new media surge for critical management theory," CRITICAL PERSPECTIVES ON ACCOUNTING, Elsevier, vol. 20(3), pages 418-444.
    10. Christian Zeller, 2010. "The Pharma-biotech Complex and Interconnected Regional Innovation Arenas," Urban Studies, Urban Studies Journal Limited, vol. 47(13), pages 2867-2894, November.
    11. Hassanzadeh, Farhad & Modarres, Mohammad & Nemati, Hamid R. & Amoako-Gyampah, Kwasi, 2014. "A robust R&D project portfolio optimization model for pharmaceutical contract research organizations," International Journal of Production Economics, Elsevier, vol. 158(C), pages 18-27.
    12. Ana Paula Faria & Natália Barbosa & Vasco Eiriz, 2015. "Firm Innovation and Co-Location in Portugal," Growth and Change, Wiley Blackwell, vol. 46(4), pages 574-592, December.
    13. Vincent Mangematin & Khalid Errabi, 2012. "The Determinants of Science-Based Cluster Growth: The Case of Nanotechnology," Environment and Planning C, , vol. 30(1), pages 128-146, February.
    14. Dornbusch, Friedrich & Brenner, Thomas, 2013. "Universities as local knowledge hubs under different technology regimes: New evidence from academic patenting," Working Papers "Firms and Region" R6/2013, Fraunhofer Institute for Systems and Innovation Research (ISI).
    15. Jerker Moodysson & Lars Coenen & Bjørn Asheim, 2008. "Explaining Spatial Patterns of Innovation: Analytical and Synthetic Modes of Knowledge Creation in the Medicon Valley Life-Science Cluster," Environment and Planning A, , vol. 40(5), pages 1040-1056, May.
    16. Christian Rammer & Dirk Czarnitzki & Alfred Spielkamp, 2009. "Innovation success of non-R&D-performers: substituting technology by management in SMEs," Small Business Economics, Springer, vol. 33(1), pages 35-58, June.
    17. Cuijpers, Maarten & Guenter, Hannes & Hussinger, Katrin, 2011. "Costs and benefits of inter-departmental innovation collaboration," Research Policy, Elsevier, vol. 40(4), pages 565-575, May.
    18. Gernot Grabher, 2002. "Cool Projects, Boring Institutions: Temporary Collaboration in Social Context," Regional Studies, Taylor & Francis Journals, vol. 36(3), pages 205-214.
    19. Love, James H. & Roper, Stephen & Bryson, John R., 2011. "Openness, knowledge, innovation and growth in UK business services," Research Policy, Elsevier, vol. 40(10), pages 1438-1452.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Davide Castellani & Katiuscia Lavoratori, 2020. "The lab and the plant: Offshore R&D and co-location with production activities," Journal of International Business Studies, Palgrave Macmillan;Academy of International Business, vol. 51(1), pages 121-137, February.
    2. Alice Lam, 2003. "Organizational Learning in Multinationals: R&D Networks of Japanese and US MNEs in the UK," Journal of Management Studies, Wiley Blackwell, vol. 40(3), pages 673-703, May.
    3. Marina Papanastassiou & Robert Pearce & Antonello Zanfei, 2020. "Changing perspectives on the internationalization of R&D and innovation by multinational enterprises: A review of the literature," Journal of International Business Studies, Palgrave Macmillan;Academy of International Business, vol. 51(4), pages 623-664, June.
    4. Frank Tannery & Paul Laurent, 2007. "Les groupes à la croisée des territoires : géostratégie de l’innovation," Revue Finance Contrôle Stratégie, revues.org, vol. 10(4), pages 179-214, December.
    5. Alexandre Almeida & António Figueiredo & Mário Rui Silva, 2011. "From Concept to Policy: Building Regional Innovation Systems in Follower Regions," European Planning Studies, Taylor & Francis Journals, vol. 19(7), pages 1331-1356, July.
    6. Casper, Steven & Matraves, Catherine, 2003. "Institutional frameworks and innovation in the German and UK pharmaceutical industry," Research Policy, Elsevier, vol. 32(10), pages 1865-1879, December.
    7. Eric Rugraff, 2017. "A Patent Analysis Of Foreign Direct Innovative R&D Activities In Central Europe: The Czech Case," International Journal of Innovation Management (ijim), World Scientific Publishing Co. Pte. Ltd., vol. 21(02), pages 1-28, February.
    8. Kazuyuki Motohashi, 2010. "R&D Activities of Manufacturing Multinationals in China: Structure, Motivations and Regional Differences," China & World Economy, Institute of World Economics and Politics, Chinese Academy of Social Sciences, vol. 18(6), pages 56-72, November.
    9. Jacqueline Senker, 2006. "Biotechnology Alliances in the European Pharmaceutical Industry: Past, Present and Future," SPRU Working Paper Series 137, SPRU - Science Policy Research Unit, University of Sussex Business School.
    10. Di Minin, Alberto & Zhang, Jieyin & Gammeltoft, Peter, 2012. "Chinese foreign direct investment in R&D in Europe: A new model of R&D internationalization?," European Management Journal, Elsevier, vol. 30(3), pages 189-203.
    11. Lorena M. D'Agostino & Grazia D. Santangelo, 2012. "The Global Fragmentation of R&D Activities: The Home Region Perspective," DRUID Working Papers 12-06, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies.
    12. Morescalchi, Andrea & Pammolli, Fabio & Penner, Orion & Petersen, Alexander M. & Riccaboni, Massimo, 2015. "The evolution of networks of innovators within and across borders: Evidence from patent data," Research Policy, Elsevier, vol. 44(3), pages 651-668.
    13. Eric Rugraff, 2014. "Foreign direct R&D investment in Central Europe: where do we stand?," Working Papers of BETA 2014-22, Bureau d'Economie Théorique et Appliquée, UDS, Strasbourg.
    14. Havas, Attila, 2010. "Diversity in firms’ innovation strategies and activities: Main findings of interviews and implications in the context of the Hungarian national," MPRA Paper 55852, University Library of Munich, Germany.
    15. Asakawa, Kazuhiro, 2001. "Organizational tension in international R&D management: the case of Japanese firms," Research Policy, Elsevier, vol. 30(5), pages 735-757, May.
    16. Steinberg, Philip J. & Procher, Vivien D. & Urbig, Diemo, 2017. "Too much or too little of R&D offshoring: The impact of captive offshoring and contract offshoring on innovation performance," Research Policy, Elsevier, vol. 46(10), pages 1810-1823.
    17. Engwall, Mats & Freilich, Jonatan, 2014. "Architectural Lock-in of the Drug Development Process," INDEK Working Paper Series 2014/4, Royal Institute of Technology, Department of Industrial Economics and Management.
    18. Pietro Moncada-Paterno-Castello & Peter Voigt & Marco Vivarelli, 2011. "Evolution of Globalised business R&D: Features, drivers, impacts," JRC Working Papers on Corporate R&D and Innovation 2011-02, Joint Research Centre.
    19. Blandinieres, Florence, 2019. "Anatomy of the medical innovation process: What are the consequences of replicability issues on innovation?," ZEW Discussion Papers 19-011, ZEW - Leibniz Centre for European Economic Research.
    20. Bas, Christian Le & Sierra, Christophe, 2002. "'Location versus home country advantages' in R&D activities: some further results on multinationals' locational strategies," Research Policy, Elsevier, vol. 31(4), pages 589-609, May.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:taf:regstd:v:36:y:2002:i:3:p:275-289. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chris Longhurst (email available below). General contact details of provider: http://www.tandfonline.com/CRES20 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.